John Blakewell and Bill Megan
Exact Sciences has appointed John Blakewell as CFO and announced that Bill Megan, senior vice president of finance, will be leaving. Blakewell will begin his new role on Jan 1, 2016 and will report to Chairman, President, and CEO Kevin Conroy. Most recently, Blakewell was CFO at Lantheus Holdings. He also serves as a director of two medical technology companies, as a member of the audit committee of Entellus Medical, and as the chairman of Keystone Dental's audit committee. Megan has served as the company's senior vice president of finance since August 2013, and will be leaving after a short transition period.
Robert Monroe
Advanced Cell Diagnostics has appointed Robert Monroe as chief medical officer. Most recently, he served as medical director and vice president of laboratory operations for Veracyte. Prior to Veracyte, Monroe served as chief medical officer of Biolmagene (acquired by Ventana, a member of the Roche Group, in 2010). He was also co-founder and chief medical officer of OncoMDx.
Timothy Henn
Redwood City, California-based molecular diagnostics firm CardioDx has named Timothy Henn CFO. He most recently served as CFO of Crescendo Biosciences, which was acquired by Myriad Genetics in 2014. Henn has also held senior finance positions with Monogram Bioscience and Incyte.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.